Usefulness of p53 and Ki-67 immunohistochemical analysis for preoperative diagnosis of extremely well-differentiated gastric adenocarcinoma

American Journal of Clinical Pathology

Volumn 118, Issue 5, 2002, Pages 683-692

  Niimi, Chikanori ^a   Goto, Hidemi ^a   Ohmiya, Naoki ^a   Niwa, Yasumasa ^a   Hayakawa, Tetsuo ^a   Nagasaka, Tetsuro ^a   Nakashima, Nobuo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Extremely well differentiated gastric adenocarcinoma; Ki 67 immunohistochemistry; Mucin histochemistry; p53 immunohistochemistry

Indexed keywords

EOSIN; HEMATOXYLIN; KI 67 ANTIGEN; MUCIN; PROTEIN P53;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CHRONIC GASTRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EXTREMELY WELL DIFFERENTIATED GASTRIC ADENOCARCINOMA; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STAINING; STOMACH ADENOCARCINOMA; STOMACH MUCOSA; ADENOCARCINOMA; BIOPSY; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; STOMACH TUMOR;

ADENOCARCINOMA; AGED; BIOPSY; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MUCINS; PREDICTIVE VALUE OF TESTS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036834439     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/NYA1-V9KQ-NVF8-MA8M     Document Type: Article

References (44)

1. Uchino S, Noguchi M, Ochiai A, et al. p53 Mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer. 1993;54:759-764.
2. Yanai H, Noguchi T, Mizumachi S, et al. A blind comparison of the effectiveness of endoscopic ultrasonography and endoscopy in staging early gastric cancer. Gut. 1999;44:361-365.
3. Eckardt VF, Giessler W, Kanzler G, et al. Clinical and morphological characteristics of early gastric cancer: a case-control study. Gastroenterology. 1990;98:708-714.
4. Ohashi S, Nakazawa S, Yoshino J. Endoscopic ultrasonography in the assessment of invasive gastric cancer. Scand J Gastroenterol. 1989;24:1039-1048.
5. Endoh Y, Tamura G, Motoyama T, et al. Well-differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in stomach. Hum Pathol. 1999;30:826-832.
6. Japanese Research Society for Gastric Cancer. The General Rules for Gastric Cancer Study. 12th ed. Tokyo, Japan: Kinbara Publication; 1993.
7. Lauren P. The two histological main types of gastric carcinomas: diffuse and so called intestinal-type of carcinoma: an attempt at a histological classification. Acta Pathol Microbiol Scand. 1965;64:31-49.
8. Lane DP. Cancer: p53, guardian of the genome. Nature. 1992;358:15-16.
9. Joypaul BV, Hopwood D, Newman EL, et al. The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. Br J Cancer. 1994;69:943-946.
10. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature. 1991;351:453-456.
11. Martin HM, Fillipe MI, Morris RW, et al. p53 expression and prognosis in gastric carcinoma. Int J Cancer. 1992;50:859-862.
12. Hong SI, Hong WE, Jang JJ, et al. Alterations of p53 gene in primary gastric cancer tissues. Anticancer Res. 1994;14:1251-1256.
13. Starzynska T, Markiewski M, Domagala W, et al. The clinical significance of p53 accumulation in gastric carcinoma. Cancer. 1996;77:2005-2012.
14. Shun CT, Wu MS, Lin JT, et al. Relationship of p53 and c-erbB-2 expression to histological features, Helicobacter pylori infection and prognosis in gastric cancer. Hepatogastroenterology. 1997;44:604-609.
15. Ogawa M, Onoda N, Maeda K, et al. A combination analysis of p53 and p21 in gastric carcinoma as a strong indicator for prognosis. Int J Mol Med. 2001;7:479-483.
16. Sasaki I, Yao T, Nawata H, et al. Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development. Cancer. 1999;85:1719-1729.
17. Fujimori Y, Akamatsu T, Ota H, et al. Proliferative markers in gastric carcinoma and organoid differentiation. Hum Pathol. 1995;26:725-734.
18. Bara J, Gautier R, Mouradian P, et al. Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis. Int J Cancer. 1991;47:304-310.
19. Baldus SE, Zibes TK, Engel S, et al. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of the gastric carcinomas. IntJ Cancer. 1998;79:133-138.
20. Barbareschi M, Girlando S, Mauri FM, et al. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas. Am J Clin Pathol. 1994;102:171-175.
21. Carrato C, Balague C, DeBolos C, et al. Differentiation apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology. 1994;107:160-172.
22. Tikkanen I, Salnela K, Hohenthal U, et al. Increased serum neutral endopeptidase activity in acute renal allograft rejection. Am J Nephrol. 1996;16:273-279.
23. Katsuyama T, Ono K, Nakayama J, et al. Recent advances in mucosubstance histochemistry. In: Kawai L, ed. Gastric Mucus and Mucus Secreting Cells. Tokyo, Japan: Excerpta Medica; 1985:3-8.
24. Katsuyama T, Ono K, Nagata T. Application of galactose oxidase mucosubstance histochemistry: galactose oxidase-Schiff reaction [abstract]. J Histochem. 1982;30:555.
25. Schulte BA, Spicer SS. Light microscopic histochemical detection of sugar residues in secretory glycoproteins of rodent and human tracheal glands with lectin-horseradish peroxidase conjugates and the galactose oxidase Schiff sequence. J Histochem Cytochem. 1983;31:391-403.
26. Akamatsu T, Katsuyama T. Histochemical demonstration of mucins in the intramucosal laminated structure of human gastric signet ring cell carcinoma and its relation to submucosal invasion. Histochem J. 1990;22:416-425.
27. Katsuyama T, Spicer SS. Histochemical differentiation of complex carbohydrates with variants of the concanavalin A-horseradish peroxidase method. J Histochem Cytochem. 1978;26:233-250.
28. Tatematsu M, Katsuyama T, Fukushima S, et al. Mucin histochemistry by paradoxical concanavalin A staining in experimental gastric cancers induced in Wistar rats by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline-1-oxide. J Natl Cancer Inst. 1980;64:835-843.
29. Kushima R, Muller W, Stolte M, et al. Differentiated p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: possible sequences of p53 alteration in stomach carcinogenesis. Virchows Arch. 1996;428:223-227.
30. Spicer SS. Diamine method for differentiating mucosubstances histochemically. J Histochem Cytochem. 1965;13:211-234.
31. Koseki K, Takizawa T, Koike M, et al. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 2000;89:724-732.
32. Martin HM, Filipe MI, Morris R, et al. p53 Expression and prognosis in gastric carcinoma. Int J Cancer. 1992;50:859-862.
33. Craanen ME, Blok P, Dekker W, et al. Chronology of p53 protein accumulation in gastric carcinogenesis. Gut. 1995;36:848-852.
34. Kakeji Y, Korenaga D, Tsujitani S, et al. Gastric cancer with p53 overexpression has high potential for metastasizing to lymph nodes. Br J Cancer. 1993;67:589-593.
35. Sasano H, Date F, Imatani A, et al. Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells. Hum Pathol. 1993;24:584-589.
36. Gabbert HE, Muller W, Schneiders A, et al. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer. 1995;76:720-726.
37. Hibi K, Mitomi H, Koizumi W, et al. Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am J Clin Pathol. 1997;108:26-34.
38. Shiao YH, Rugge M, Correa P, et al. p53 Alteration in gastric precancerous lesions. Am J Pathol. 1994;144:511-517.
39. Satoh K, Kihira K, Kawata H, et al. p53 expression in the gastric mucosa before and after eradication of Helicobacter pylon. Helicobacter. 2001;1:31-36.
40. Jones NL, Shannon PT, Cutz E, et al. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol. 1997;151:1695-1703.
41. Hoshi T, Sasano H, Kato K, et al. Cell damage and proliferation in human gastric mucosa infected by Helicobacter pylon: a comparison before and after H pylori eradication in non-atrophic gastritis. Hum Pathol. 1999;30:1412-1417.
42. Imatani A, Sasano H, Yabuki N, et al. In situ analysis of tissue dynamics and expression in human gastric mucosa. J Pathol. 1996;179:39-42.
43. Ikeguchi M, Saito H, Kondo A, et al. Mutated p53 protein expression and proliferative activity in advanced gastric cancer. Hepatogastroenterology. 1999;46:2648-2653.
44. Egashira Y, Shimoda T, Ikegami M, et al. Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int. 1999;49:55-61.